Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3764642019 | Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3764643012 | Product containing precisely amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet | Has presentation strength numerator unit | Unit | true | Inferred relationship | Some | 1 | |
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet | Has presentation strength numerator unit | Unit | true | Inferred relationship | Some | 2 | |
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet | Has precise active ingredient | Amylase (substance) | true | Inferred relationship | Some | 2 | |
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet | Has presentation strength denominator value | un | false | Inferred relationship | Some | 3 | |
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet | Has presentation strength numerator unit | Unit | true | Inferred relationship | Some | 3 | |
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet | a une forme pharmaceutique (attribut) | Oral tablet | true | Inferred relationship | Some | ||
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet | Count of base of active ingredient | trois | false | Inferred relationship | Some | ||
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet | Has basis of strength substance (attribute) | Amylase (substance) | true | Inferred relationship | Some | 2 | |
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet | Has presentation strength numerator value (attribute) | 6000 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 3 | |
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet | est un(e) (attribut) | Product containing only amylase and endopeptidase and triacylglycerol lipase in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet | Has presentation strength numerator value (attribute) | 16000 (qualifier value) | false | Inferred relationship | Some | 3 | |
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet | Has precise active ingredient | lipase | true | Inferred relationship | Some | 3 | |
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet | Has basis of strength substance (attribute) | lipase | true | Inferred relationship | Some | 3 | |
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet | Has basis of strength substance (attribute) | Endopeptidase | true | Inferred relationship | Some | 1 | |
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet | Has precise active ingredient | Endopeptidase | true | Inferred relationship | Some | 1 | |
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet | Has presentation strength numerator value (attribute) | 6000 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet | Plays role | Digestant therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR